Ambrx
Biopharmaceutical innovations
About Ambrx
Ambrx (Nasdaq: AMAM) is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. Ambrx is advancing a focused portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications. The company was spun out of The Scripps Research Institute in 2003 and has several product candidates involving ADCs and other aspects of Ambrx’s protein engineering technology.
Find Remote Jobs
Connect with top companies hiring for remote jobs, work-from-home roles, and 100% online jobs worldwide.
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.